Index by author

January 01 2000; volume 23 issue 1

A

  1. Alberiche, M

    1. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
      E Bonora, G Targher, M Alberiche, R C Bonadonna, F Saggiani, M B Zenere, T Monauni and M Muggeo
      Diabetes Care 2000 Jan; 23 (1): 57-63. https://doi.org/10.2337/diacare.23.1.57

  2. Alberti, K G

    1. Impaired fasting glucose: how low should it go?
      J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto and K G Alberti
      Diabetes Care 2000 Jan; 23 (1): 34-39. https://doi.org/10.2337/diacare.23.1.34

  3. Andersen, R E

    1. Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.
      A R Shuldiner, W Nguyen, W H Kao, B A Beamer, R E Andersen, R Pratley and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 126-127. https://doi.org/10.2337/diacare.23.1.126a

  4. Artuch, R

    1. Total homocysteine in patients with type 1 diabetes.
      C Pavía, I Ferrer, C Valls, R Artuch, C Colomé and M A Vilaseca
      Diabetes Care 2000 Jan; 23 (1): 84-87. https://doi.org/10.2337/diacare.23.1.84

B

  1. Babka, C

    1. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis.
      R W Holl, C Buck, C Babka, A Wolf and A Thon
      Diabetes Care 2000 Jan; 23 (1): 126. https://doi.org/10.2337/diacare.23.1.126b

  2. Bayraktar, M

    1. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
      A Gürlek, M Bayraktar and S Kirazli
      Diabetes Care 2000 Jan; 23 (1): 88-92. https://doi.org/10.2337/diacare.23.1.88

  3. Beamer, B A

    1. Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.
      A R Shuldiner, W Nguyen, W H Kao, B A Beamer, R E Andersen, R Pratley and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 126-127. https://doi.org/10.2337/diacare.23.1.126a

  4. Bell, D S

    1. Late-onset troglitazone-induced hepatic dysfunction.
      D S Bell and F Ovalle
      Diabetes Care 2000 Jan; 23 (1): 128-129. https://doi.org/10.2337/diacare.23.1.128

  5. Blair, S N

    1. Alcohol intake and incidence of type 2 diabetes in men.
      M Wei, L W Gibbons, T L Mitchell, J B Kampert and S N Blair
      Diabetes Care 2000 Jan; 23 (1): 18-22. https://doi.org/10.2337/diacare.23.1.18

  6. Bloomgarden, Z T

    1. American Diabetes Association Annual Meeting, 1999: diabetes and obesity.
      Z T Bloomgarden
      Diabetes Care 2000 Jan; 23 (1): 118-124. https://doi.org/10.2337/diacare.23.1.118

  7. Boden-Albala, B

    1. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.
      G B Phillips, C H Tuck, T Y Jing, B Boden-Albala, I F Lin, N Dahodwala and R L Sacco
      Diabetes Care 2000 Jan; 23 (1): 74-79. https://doi.org/10.2337/diacare.23.1.74

  8. Bonadonna, R C

    1. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
      M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti and G Verlato
      Diabetes Care 2000 Jan; 23 (1): 45-50. https://doi.org/10.2337/diacare.23.1.45
    2. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
      E Bonora, G Targher, M Alberiche, R C Bonadonna, F Saggiani, M B Zenere, T Monauni and M Muggeo
      Diabetes Care 2000 Jan; 23 (1): 57-63. https://doi.org/10.2337/diacare.23.1.57

  9. Bonora, E

    1. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
      M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti and G Verlato
      Diabetes Care 2000 Jan; 23 (1): 45-50. https://doi.org/10.2337/diacare.23.1.45
    2. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
      E Bonora, G Targher, M Alberiche, R C Bonadonna, F Saggiani, M B Zenere, T Monauni and M Muggeo
      Diabetes Care 2000 Jan; 23 (1): 57-63. https://doi.org/10.2337/diacare.23.1.57

  10. Bouter, L M

    1. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study.
      F de Vegt, J M Dekker, C D Stehouwer, G Nijpels, L M Bouter and R J Heine
      Diabetes Care 2000 Jan; 23 (1): 40-44. https://doi.org/10.2337/diacare.23.1.40

  11. Brancati, F L

    1. Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.
      A R Shuldiner, W Nguyen, W H Kao, B A Beamer, R E Andersen, R Pratley and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 126-127. https://doi.org/10.2337/diacare.23.1.126a
    2. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes.
      T L Gary, R M Crum, L Cooper-Patrick, D Ford and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 23-29. https://doi.org/10.2337/diacare.23.1.23

  12. Brighenti, F

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

  13. Brun, E

    1. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
      M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti and G Verlato
      Diabetes Care 2000 Jan; 23 (1): 45-50. https://doi.org/10.2337/diacare.23.1.45

  14. Buck, C

    1. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis.
      R W Holl, C Buck, C Babka, A Wolf and A Thon
      Diabetes Care 2000 Jan; 23 (1): 126. https://doi.org/10.2337/diacare.23.1.126b

  15. Burgos, R

    1. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
      R Burgos, C Mateo, A Cantón, C Hernández, J Mesa and R Simó
      Diabetes Care 2000 Jan; 23 (1): 80-83. https://doi.org/10.2337/diacare.23.1.80

C

  1. Cantón, A

    1. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
      R Burgos, C Mateo, A Cantón, C Hernández, J Mesa and R Simó
      Diabetes Care 2000 Jan; 23 (1): 80-83. https://doi.org/10.2337/diacare.23.1.80

  2. Chitson, P

    1. Impaired fasting glucose: how low should it go?
      J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto and K G Alberti
      Diabetes Care 2000 Jan; 23 (1): 34-39. https://doi.org/10.2337/diacare.23.1.34

  3. Coleman, K J

    1. Gestational diabetes: is a higher cesarean section rate inevitable?
      R G Moses, S J Knights, E M Lucas, M Moses, K G Russell, K J Coleman and W S Davis
      Diabetes Care 2000 Jan; 23 (1): 15-17. https://doi.org/10.2337/diacare.23.1.15

  4. Colomé, C

    1. Total homocysteine in patients with type 1 diabetes.
      C Pavía, I Ferrer, C Valls, R Artuch, C Colomé and M A Vilaseca
      Diabetes Care 2000 Jan; 23 (1): 84-87. https://doi.org/10.2337/diacare.23.1.84

  5. Cooper-Patrick, L

    1. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes.
      T L Gary, R M Crum, L Cooper-Patrick, D Ford and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 23-29. https://doi.org/10.2337/diacare.23.1.23

  6. Crum, R M

    1. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes.
      T L Gary, R M Crum, L Cooper-Patrick, D Ford and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 23-29. https://doi.org/10.2337/diacare.23.1.23

D

  1. Dahodwala, N

    1. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.
      G B Phillips, C H Tuck, T Y Jing, B Boden-Albala, I F Lin, N Dahodwala and R L Sacco
      Diabetes Care 2000 Jan; 23 (1): 74-79. https://doi.org/10.2337/diacare.23.1.74

  2. Davis, C

    1. Pancreas and islet transplantation for patients with diabetes.
      R P Robertson, C Davis, J Larsen, R Stratta and D E Sutherland
      Diabetes Care 2000 Jan; 23 (1): 112-116. https://doi.org/10.2337/diacare.23.1.112

  3. Davis, W S

    1. Gestational diabetes: is a higher cesarean section rate inevitable?
      R G Moses, S J Knights, E M Lucas, M Moses, K G Russell, K J Coleman and W S Davis
      Diabetes Care 2000 Jan; 23 (1): 15-17. https://doi.org/10.2337/diacare.23.1.15

  4. de Courten, M

    1. Impaired fasting glucose: how low should it go?
      J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto and K G Alberti
      Diabetes Care 2000 Jan; 23 (1): 34-39. https://doi.org/10.2337/diacare.23.1.34

  5. Dekker, J M

    1. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study.
      F de Vegt, J M Dekker, C D Stehouwer, G Nijpels, L M Bouter and R J Heine
      Diabetes Care 2000 Jan; 23 (1): 40-44. https://doi.org/10.2337/diacare.23.1.40

  6. de Vegt, F

    1. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study.
      F de Vegt, J M Dekker, C D Stehouwer, G Nijpels, L M Bouter and R J Heine
      Diabetes Care 2000 Jan; 23 (1): 40-44. https://doi.org/10.2337/diacare.23.1.40

  7. Doi, K

    1. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.
      A Taniguchi, M Fukushima, M Sakai, I Nagata, K Doi, S Nagasaka, K Tokuyama and Y Nakai
      Diabetes Care 2000 Jan; 23 (1): 127-128. https://doi.org/10.2337/diacare.23.1.127

  8. Dowse, G K

    1. Impaired fasting glucose: how low should it go?
      J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto and K G Alberti
      Diabetes Care 2000 Jan; 23 (1): 34-39. https://doi.org/10.2337/diacare.23.1.34

F

  1. Fagerudd, J A

    1. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.
      L Tarnow, P Rossing, F S Nielsen, J A Fagerudd, O Poirier and H H Parving
      Diabetes Care 2000 Jan; 23 (1): 30-33. https://doi.org/10.2337/diacare.23.1.30

  2. Ferrer, I

    1. Total homocysteine in patients with type 1 diabetes.
      C Pavía, I Ferrer, C Valls, R Artuch, C Colomé and M A Vilaseca
      Diabetes Care 2000 Jan; 23 (1): 84-87. https://doi.org/10.2337/diacare.23.1.84

  3. Ford, D

    1. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes.
      T L Gary, R M Crum, L Cooper-Patrick, D Ford and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 23-29. https://doi.org/10.2337/diacare.23.1.23

  4. Frias, J P

    1. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
      J P Frias, J G Yu, Y T Kruszynska and J M Olefsky
      Diabetes Care 2000 Jan; 23 (1): 64-69. https://doi.org/10.2337/diacare.23.1.64

  5. Fukushima, M

    1. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.
      A Taniguchi, M Fukushima, M Sakai, I Nagata, K Doi, S Nagasaka, K Tokuyama and Y Nakai
      Diabetes Care 2000 Jan; 23 (1): 127-128. https://doi.org/10.2337/diacare.23.1.127

G

  1. Gary, T L

    1. Depressive symptoms and metabolic control in African-Americans with type 2 diabetes.
      T L Gary, R M Crum, L Cooper-Patrick, D Ford and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 23-29. https://doi.org/10.2337/diacare.23.1.23

  2. Gibbons, L W

    1. Alcohol intake and incidence of type 2 diabetes in men.
      M Wei, L W Gibbons, T L Mitchell, J B Kampert and S N Blair
      Diabetes Care 2000 Jan; 23 (1): 18-22. https://doi.org/10.2337/diacare.23.1.18

  3. Gohdes, D

    1. Diabetes screening practices among individuals aged 45 years and older.
      T S Harwell, J G Smilie, J M McDowall, S D Helgerson and D Gohdes
      Diabetes Care 2000 Jan; 23 (1): 125-126. https://doi.org/10.2337/diacare.23.1.125

  4. Gougeon, R

    1. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.
      R Gougeon, K Styhler, J A Morais, P J Jones and E B Marliss
      Diabetes Care 2000 Jan; 23 (1): 1-8. https://doi.org/10.2337/diacare.23.1.1

  5. Gürlek, A

    1. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
      A Gürlek, M Bayraktar and S Kirazli
      Diabetes Care 2000 Jan; 23 (1): 88-92. https://doi.org/10.2337/diacare.23.1.88

H

  1. Harwell, T S

    1. Diabetes screening practices among individuals aged 45 years and older.
      T S Harwell, J G Smilie, J M McDowall, S D Helgerson and D Gohdes
      Diabetes Care 2000 Jan; 23 (1): 125-126. https://doi.org/10.2337/diacare.23.1.125

  2. Heine, R J

    1. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study.
      F de Vegt, J M Dekker, C D Stehouwer, G Nijpels, L M Bouter and R J Heine
      Diabetes Care 2000 Jan; 23 (1): 40-44. https://doi.org/10.2337/diacare.23.1.40

  3. Helgerson, S D

    1. Diabetes screening practices among individuals aged 45 years and older.
      T S Harwell, J G Smilie, J M McDowall, S D Helgerson and D Gohdes
      Diabetes Care 2000 Jan; 23 (1): 125-126. https://doi.org/10.2337/diacare.23.1.125

  4. Hernández, C

    1. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
      R Burgos, C Mateo, A Cantón, C Hernández, J Mesa and R Simó
      Diabetes Care 2000 Jan; 23 (1): 80-83. https://doi.org/10.2337/diacare.23.1.80

  5. Hodge, A M

    1. Impaired fasting glucose: how low should it go?
      J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto and K G Alberti
      Diabetes Care 2000 Jan; 23 (1): 34-39. https://doi.org/10.2337/diacare.23.1.34

  6. Holl, R W

    1. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis.
      R W Holl, C Buck, C Babka, A Wolf and A Thon
      Diabetes Care 2000 Jan; 23 (1): 126. https://doi.org/10.2337/diacare.23.1.126b

J

  1. Jenkins, D J

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

  2. Jing, T Y

    1. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.
      G B Phillips, C H Tuck, T Y Jing, B Boden-Albala, I F Lin, N Dahodwala and R L Sacco
      Diabetes Care 2000 Jan; 23 (1): 74-79. https://doi.org/10.2337/diacare.23.1.74

  3. Jones, P J

    1. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.
      R Gougeon, K Styhler, J A Morais, P J Jones and E B Marliss
      Diabetes Care 2000 Jan; 23 (1): 1-8. https://doi.org/10.2337/diacare.23.1.1

  4. Josse, R G

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

K

  1. Kampert, J B

    1. Alcohol intake and incidence of type 2 diabetes in men.
      M Wei, L W Gibbons, T L Mitchell, J B Kampert and S N Blair
      Diabetes Care 2000 Jan; 23 (1): 18-22. https://doi.org/10.2337/diacare.23.1.18

  2. Kao, W H

    1. Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.
      A R Shuldiner, W Nguyen, W H Kao, B A Beamer, R E Andersen, R Pratley and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 126-127. https://doi.org/10.2337/diacare.23.1.126a

  3. Karhapää, P

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

  4. Kärkkäinen, P

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

  5. Kekäläinen, P

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

  6. Kimura, S

    1. Glyburide-induced hemolysis in myelodysplastic syndrome.
      H Noto, K Tsukamoto and S Kimura
      Diabetes Care 2000 Jan; 23 (1): 129. https://doi.org/10.2337/diacare.23.1.129b

  7. Kirazli, S

    1. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
      A Gürlek, M Bayraktar and S Kirazli
      Diabetes Care 2000 Jan; 23 (1): 88-92. https://doi.org/10.2337/diacare.23.1.88

  8. Knights, S J

    1. Gestational diabetes: is a higher cesarean section rate inevitable?
      R G Moses, S J Knights, E M Lucas, M Moses, K G Russell, K J Coleman and W S Davis
      Diabetes Care 2000 Jan; 23 (1): 15-17. https://doi.org/10.2337/diacare.23.1.15

  9. Kruszynska, Y T

    1. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
      J P Frias, J G Yu, Y T Kruszynska and J M Olefsky
      Diabetes Care 2000 Jan; 23 (1): 64-69. https://doi.org/10.2337/diacare.23.1.64

  10. Kuusisto, J

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

L

  1. Laakso, M

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

  2. Larsen, J

    1. Pancreas and islet transplantation for patients with diabetes.
      R P Robertson, C Davis, J Larsen, R Stratta and D E Sutherland
      Diabetes Care 2000 Jan; 23 (1): 112-116. https://doi.org/10.2337/diacare.23.1.112

  3. Larson, T S

    1. Trends in persistent proteinuria in adult-onset diabetes: a population-based study.
      T S Larson, N Santanello, S Shahinfar, P C O'Brien, P J Palumbo, L J Melton and C L Leibson
      Diabetes Care 2000 Jan; 23 (1): 51-56. https://doi.org/10.2337/diacare.23.1.51

  4. Leibson, C L

    1. Trends in persistent proteinuria in adult-onset diabetes: a population-based study.
      T S Larson, N Santanello, S Shahinfar, P C O'Brien, P J Palumbo, L J Melton and C L Leibson
      Diabetes Care 2000 Jan; 23 (1): 51-56. https://doi.org/10.2337/diacare.23.1.51

  5. Leiter, L A

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

  6. Lin, I F

    1. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.
      G B Phillips, C H Tuck, T Y Jing, B Boden-Albala, I F Lin, N Dahodwala and R L Sacco
      Diabetes Care 2000 Jan; 23 (1): 74-79. https://doi.org/10.2337/diacare.23.1.74

  7. Lucas, E M

    1. Gestational diabetes: is a higher cesarean section rate inevitable?
      R G Moses, S J Knights, E M Lucas, M Moses, K G Russell, K J Coleman and W S Davis
      Diabetes Care 2000 Jan; 23 (1): 15-17. https://doi.org/10.2337/diacare.23.1.15

M

  1. Mabuchi, H

    1. Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.
      Y Murase, T Wakasugi, K Yagi and H Mabuchi
      Diabetes Care 2000 Jan; 23 (1): 131-132. https://doi.org/10.2337/diacare.23.1.131

  2. Markkanen, A

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

  3. Marliss, E B

    1. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.
      R Gougeon, K Styhler, J A Morais, P J Jones and E B Marliss
      Diabetes Care 2000 Jan; 23 (1): 1-8. https://doi.org/10.2337/diacare.23.1.1

  4. Mateo, C

    1. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
      R Burgos, C Mateo, A Cantón, C Hernández, J Mesa and R Simó
      Diabetes Care 2000 Jan; 23 (1): 80-83. https://doi.org/10.2337/diacare.23.1.80

  5. Maule, S

    1. Effects of exposure at an altitude of 3,000 m on performance of glucose meters.
      O Pecchio, S Maule, M Migliardi, M Trento and M Veglio
      Diabetes Care 2000 Jan; 23 (1): 129-131. https://doi.org/10.2337/diacare.23.1.129a

  6. McDowall, J M

    1. Diabetes screening practices among individuals aged 45 years and older.
      T S Harwell, J G Smilie, J M McDowall, S D Helgerson and D Gohdes
      Diabetes Care 2000 Jan; 23 (1): 125-126. https://doi.org/10.2337/diacare.23.1.125

  7. Melton, L J

    1. Trends in persistent proteinuria in adult-onset diabetes: a population-based study.
      T S Larson, N Santanello, S Shahinfar, P C O'Brien, P J Palumbo, L J Melton and C L Leibson
      Diabetes Care 2000 Jan; 23 (1): 51-56. https://doi.org/10.2337/diacare.23.1.51

  8. Mesa, J

    1. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
      R Burgos, C Mateo, A Cantón, C Hernández, J Mesa and R Simó
      Diabetes Care 2000 Jan; 23 (1): 80-83. https://doi.org/10.2337/diacare.23.1.80

  9. Migliardi, M

    1. Effects of exposure at an altitude of 3,000 m on performance of glucose meters.
      O Pecchio, S Maule, M Migliardi, M Trento and M Veglio
      Diabetes Care 2000 Jan; 23 (1): 129-131. https://doi.org/10.2337/diacare.23.1.129a

  10. Mitchell, T L

    1. Alcohol intake and incidence of type 2 diabetes in men.
      M Wei, L W Gibbons, T L Mitchell, J B Kampert and S N Blair
      Diabetes Care 2000 Jan; 23 (1): 18-22. https://doi.org/10.2337/diacare.23.1.18

  11. Moghetti, P

    1. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
      M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti and G Verlato
      Diabetes Care 2000 Jan; 23 (1): 45-50. https://doi.org/10.2337/diacare.23.1.45

  12. Monauni, T

    1. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
      E Bonora, G Targher, M Alberiche, R C Bonadonna, F Saggiani, M B Zenere, T Monauni and M Muggeo
      Diabetes Care 2000 Jan; 23 (1): 57-63. https://doi.org/10.2337/diacare.23.1.57

  13. Morais, J A

    1. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.
      R Gougeon, K Styhler, J A Morais, P J Jones and E B Marliss
      Diabetes Care 2000 Jan; 23 (1): 1-8. https://doi.org/10.2337/diacare.23.1.1

  14. Moses, M

    1. Gestational diabetes: is a higher cesarean section rate inevitable?
      R G Moses, S J Knights, E M Lucas, M Moses, K G Russell, K J Coleman and W S Davis
      Diabetes Care 2000 Jan; 23 (1): 15-17. https://doi.org/10.2337/diacare.23.1.15

  15. Moses, R G

    1. Gestational diabetes: is a higher cesarean section rate inevitable?
      R G Moses, S J Knights, E M Lucas, M Moses, K G Russell, K J Coleman and W S Davis
      Diabetes Care 2000 Jan; 23 (1): 15-17. https://doi.org/10.2337/diacare.23.1.15

  16. Muggeo, M

    1. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
      M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti and G Verlato
      Diabetes Care 2000 Jan; 23 (1): 45-50. https://doi.org/10.2337/diacare.23.1.45
    2. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
      E Bonora, G Targher, M Alberiche, R C Bonadonna, F Saggiani, M B Zenere, T Monauni and M Muggeo
      Diabetes Care 2000 Jan; 23 (1): 57-63. https://doi.org/10.2337/diacare.23.1.57

  17. Murase, Y

    1. Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.
      Y Murase, T Wakasugi, K Yagi and H Mabuchi
      Diabetes Care 2000 Jan; 23 (1): 131-132. https://doi.org/10.2337/diacare.23.1.131

  18. Mykkänen, L

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

N

  1. Nagasaka, S

    1. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.
      A Taniguchi, M Fukushima, M Sakai, I Nagata, K Doi, S Nagasaka, K Tokuyama and Y Nakai
      Diabetes Care 2000 Jan; 23 (1): 127-128. https://doi.org/10.2337/diacare.23.1.127

  2. Nagata, I

    1. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.
      A Taniguchi, M Fukushima, M Sakai, I Nagata, K Doi, S Nagasaka, K Tokuyama and Y Nakai
      Diabetes Care 2000 Jan; 23 (1): 127-128. https://doi.org/10.2337/diacare.23.1.127

  3. Nakai, Y

    1. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.
      A Taniguchi, M Fukushima, M Sakai, I Nagata, K Doi, S Nagasaka, K Tokuyama and Y Nakai
      Diabetes Care 2000 Jan; 23 (1): 127-128. https://doi.org/10.2337/diacare.23.1.127

  4. Nguyen, W

    1. Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.
      A R Shuldiner, W Nguyen, W H Kao, B A Beamer, R E Andersen, R Pratley and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 126-127. https://doi.org/10.2337/diacare.23.1.126a

  5. Nielsen, F S

    1. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.
      L Tarnow, P Rossing, F S Nielsen, J A Fagerudd, O Poirier and H H Parving
      Diabetes Care 2000 Jan; 23 (1): 30-33. https://doi.org/10.2337/diacare.23.1.30

  6. Nijpels, G

    1. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study.
      F de Vegt, J M Dekker, C D Stehouwer, G Nijpels, L M Bouter and R J Heine
      Diabetes Care 2000 Jan; 23 (1): 40-44. https://doi.org/10.2337/diacare.23.1.40

  7. Niskanen, L

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

  8. Noto, H

    1. Glyburide-induced hemolysis in myelodysplastic syndrome.
      H Noto, K Tsukamoto and S Kimura
      Diabetes Care 2000 Jan; 23 (1): 129. https://doi.org/10.2337/diacare.23.1.129b

  9. Novokmet, R

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

O

  1. O'Brien, P C

    1. Trends in persistent proteinuria in adult-onset diabetes: a population-based study.
      T S Larson, N Santanello, S Shahinfar, P C O'Brien, P J Palumbo, L J Melton and C L Leibson
      Diabetes Care 2000 Jan; 23 (1): 51-56. https://doi.org/10.2337/diacare.23.1.51

  2. Olefsky, J M

    1. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
      J P Frias, J G Yu, Y T Kruszynska and J M Olefsky
      Diabetes Care 2000 Jan; 23 (1): 64-69. https://doi.org/10.2337/diacare.23.1.64

  3. Ovalle, F

    1. Late-onset troglitazone-induced hepatic dysfunction.
      D S Bell and F Ovalle
      Diabetes Care 2000 Jan; 23 (1): 128-129. https://doi.org/10.2337/diacare.23.1.128

  4. Owen, R

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

P

  1. Palumbo, P J

    1. Trends in persistent proteinuria in adult-onset diabetes: a population-based study.
      T S Larson, N Santanello, S Shahinfar, P C O'Brien, P J Palumbo, L J Melton and C L Leibson
      Diabetes Care 2000 Jan; 23 (1): 51-56. https://doi.org/10.2337/diacare.23.1.51

  2. Parving, H H

    1. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.
      L Tarnow, P Rossing, F S Nielsen, J A Fagerudd, O Poirier and H H Parving
      Diabetes Care 2000 Jan; 23 (1): 30-33. https://doi.org/10.2337/diacare.23.1.30

  3. Pavía, C

    1. Total homocysteine in patients with type 1 diabetes.
      C Pavía, I Ferrer, C Valls, R Artuch, C Colomé and M A Vilaseca
      Diabetes Care 2000 Jan; 23 (1): 84-87. https://doi.org/10.2337/diacare.23.1.84

  4. Pecchio, O

    1. Effects of exposure at an altitude of 3,000 m on performance of glucose meters.
      O Pecchio, S Maule, M Migliardi, M Trento and M Veglio
      Diabetes Care 2000 Jan; 23 (1): 129-131. https://doi.org/10.2337/diacare.23.1.129a

  5. Phillips, G B

    1. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.
      G B Phillips, C H Tuck, T Y Jing, B Boden-Albala, I F Lin, N Dahodwala and R L Sacco
      Diabetes Care 2000 Jan; 23 (1): 74-79. https://doi.org/10.2337/diacare.23.1.74

  6. Pihlajamäki, J

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

  7. Poirier, O

    1. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.
      L Tarnow, P Rossing, F S Nielsen, J A Fagerudd, O Poirier and H H Parving
      Diabetes Care 2000 Jan; 23 (1): 30-33. https://doi.org/10.2337/diacare.23.1.30

  8. Poland, G A

    1. Use of influenza and pneumococcal vaccines in people with diabetes.
      S A Smith and G A Poland
      Diabetes Care 2000 Jan; 23 (1): 95-108. https://doi.org/10.2337/diacare.23.1.95

  9. Pratley, R

    1. Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.
      A R Shuldiner, W Nguyen, W H Kao, B A Beamer, R E Andersen, R Pratley and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 126-127. https://doi.org/10.2337/diacare.23.1.126a

R

  1. Rissanen, J

    1. Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.
      J Rissanen, A Markkanen, P Kärkkäinen, J Pihlajamäki, P Kekäläinen, L Mykkänen, J Kuusisto, P Karhapää, L Niskanen and M Laakso
      Diabetes Care 2000 Jan; 23 (1): 70-73. https://doi.org/10.2337/diacare.23.1.70

  2. Robertson, R P

    1. Pancreas and islet transplantation for patients with diabetes.
      R P Robertson, C Davis, J Larsen, R Stratta and D E Sutherland
      Diabetes Care 2000 Jan; 23 (1): 112-116. https://doi.org/10.2337/diacare.23.1.112

  3. Rossing, P

    1. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.
      L Tarnow, P Rossing, F S Nielsen, J A Fagerudd, O Poirier and H H Parving
      Diabetes Care 2000 Jan; 23 (1): 30-33. https://doi.org/10.2337/diacare.23.1.30

  4. Russell, K G

    1. Gestational diabetes: is a higher cesarean section rate inevitable?
      R G Moses, S J Knights, E M Lucas, M Moses, K G Russell, K J Coleman and W S Davis
      Diabetes Care 2000 Jan; 23 (1): 15-17. https://doi.org/10.2337/diacare.23.1.15

S

  1. Sacco, R L

    1. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.
      G B Phillips, C H Tuck, T Y Jing, B Boden-Albala, I F Lin, N Dahodwala and R L Sacco
      Diabetes Care 2000 Jan; 23 (1): 74-79. https://doi.org/10.2337/diacare.23.1.74

  2. Saggiani, F

    1. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
      E Bonora, G Targher, M Alberiche, R C Bonadonna, F Saggiani, M B Zenere, T Monauni and M Muggeo
      Diabetes Care 2000 Jan; 23 (1): 57-63. https://doi.org/10.2337/diacare.23.1.57

  3. Sakai, M

    1. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.
      A Taniguchi, M Fukushima, M Sakai, I Nagata, K Doi, S Nagasaka, K Tokuyama and Y Nakai
      Diabetes Care 2000 Jan; 23 (1): 127-128. https://doi.org/10.2337/diacare.23.1.127

  4. Santanello, N

    1. Trends in persistent proteinuria in adult-onset diabetes: a population-based study.
      T S Larson, N Santanello, S Shahinfar, P C O'Brien, P J Palumbo, L J Melton and C L Leibson
      Diabetes Care 2000 Jan; 23 (1): 51-56. https://doi.org/10.2337/diacare.23.1.51

  5. Shahinfar, S

    1. Trends in persistent proteinuria in adult-onset diabetes: a population-based study.
      T S Larson, N Santanello, S Shahinfar, P C O'Brien, P J Palumbo, L J Melton and C L Leibson
      Diabetes Care 2000 Jan; 23 (1): 51-56. https://doi.org/10.2337/diacare.23.1.51

  6. Shaw, J E

    1. Impaired fasting glucose: how low should it go?
      J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto and K G Alberti
      Diabetes Care 2000 Jan; 23 (1): 34-39. https://doi.org/10.2337/diacare.23.1.34

  7. Shuldiner, A R

    1. Pro115Gln peroxisome proliferator-activated receptor-gamma and obesity.
      A R Shuldiner, W Nguyen, W H Kao, B A Beamer, R E Andersen, R Pratley and F L Brancati
      Diabetes Care 2000 Jan; 23 (1): 126-127. https://doi.org/10.2337/diacare.23.1.126a

  8. Sievenpiper, J L

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

  9. Simó, R

    1. Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.
      R Burgos, C Mateo, A Cantón, C Hernández, J Mesa and R Simó
      Diabetes Care 2000 Jan; 23 (1): 80-83. https://doi.org/10.2337/diacare.23.1.80

  10. Smilie, J G

    1. Diabetes screening practices among individuals aged 45 years and older.
      T S Harwell, J G Smilie, J M McDowall, S D Helgerson and D Gohdes
      Diabetes Care 2000 Jan; 23 (1): 125-126. https://doi.org/10.2337/diacare.23.1.125

  11. Smith, S A

    1. Use of influenza and pneumococcal vaccines in people with diabetes.
      S A Smith and G A Poland
      Diabetes Care 2000 Jan; 23 (1): 95-108. https://doi.org/10.2337/diacare.23.1.95

  12. Spadafora, P

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

  13. Stehouwer, C D

    1. Similar 9-year mortality risks and reproducibility for the World Health Organization and American Diabetes Association glucose tolerance categories: the Hoorn Study.
      F de Vegt, J M Dekker, C D Stehouwer, G Nijpels, L M Bouter and R J Heine
      Diabetes Care 2000 Jan; 23 (1): 40-44. https://doi.org/10.2337/diacare.23.1.40

  14. Stratta, R

    1. Pancreas and islet transplantation for patients with diabetes.
      R P Robertson, C Davis, J Larsen, R Stratta and D E Sutherland
      Diabetes Care 2000 Jan; 23 (1): 112-116. https://doi.org/10.2337/diacare.23.1.112

  15. Styhler, K

    1. Effects of oral hypoglycemic agents and diet on protein metabolism in type 2 diabetes.
      R Gougeon, K Styhler, J A Morais, P J Jones and E B Marliss
      Diabetes Care 2000 Jan; 23 (1): 1-8. https://doi.org/10.2337/diacare.23.1.1

  16. Sutherland, D E

    1. Pancreas and islet transplantation for patients with diabetes.
      R P Robertson, C Davis, J Larsen, R Stratta and D E Sutherland
      Diabetes Care 2000 Jan; 23 (1): 112-116. https://doi.org/10.2337/diacare.23.1.112

  17. Swilley, J A

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

T

  1. Taniguchi, A

    1. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.
      A Taniguchi, M Fukushima, M Sakai, I Nagata, K Doi, S Nagasaka, K Tokuyama and Y Nakai
      Diabetes Care 2000 Jan; 23 (1): 127-128. https://doi.org/10.2337/diacare.23.1.127

  2. Targher, G

    1. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
      E Bonora, G Targher, M Alberiche, R C Bonadonna, F Saggiani, M B Zenere, T Monauni and M Muggeo
      Diabetes Care 2000 Jan; 23 (1): 57-63. https://doi.org/10.2337/diacare.23.1.57

  3. Tarnow, L

    1. Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy.
      L Tarnow, P Rossing, F S Nielsen, J A Fagerudd, O Poirier and H H Parving
      Diabetes Care 2000 Jan; 23 (1): 30-33. https://doi.org/10.2337/diacare.23.1.30

  4. Thon, A

    1. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis.
      R W Holl, C Buck, C Babka, A Wolf and A Thon
      Diabetes Care 2000 Jan; 23 (1): 126. https://doi.org/10.2337/diacare.23.1.126b

  5. Tokuyama, K

    1. Insulin secretion, insulin sensitivity, and glucose effectiveness in nonobese individuals with varying degrees of glucose tolerance.
      A Taniguchi, M Fukushima, M Sakai, I Nagata, K Doi, S Nagasaka, K Tokuyama and Y Nakai
      Diabetes Care 2000 Jan; 23 (1): 127-128. https://doi.org/10.2337/diacare.23.1.127

  6. Trento, M

    1. Effects of exposure at an altitude of 3,000 m on performance of glucose meters.
      O Pecchio, S Maule, M Migliardi, M Trento and M Veglio
      Diabetes Care 2000 Jan; 23 (1): 129-131. https://doi.org/10.2337/diacare.23.1.129a

  7. Tsukamoto, K

    1. Glyburide-induced hemolysis in myelodysplastic syndrome.
      H Noto, K Tsukamoto and S Kimura
      Diabetes Care 2000 Jan; 23 (1): 129. https://doi.org/10.2337/diacare.23.1.129b

  8. Tuck, C H

    1. Association of hyperandrogenemia and hyperestrogenemia with type 2 diabetes in Hispanic postmenopausal women.
      G B Phillips, C H Tuck, T Y Jing, B Boden-Albala, I F Lin, N Dahodwala and R L Sacco
      Diabetes Care 2000 Jan; 23 (1): 74-79. https://doi.org/10.2337/diacare.23.1.74

  9. Tuomilehto, J

    1. Impaired fasting glucose: how low should it go?
      J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto and K G Alberti
      Diabetes Care 2000 Jan; 23 (1): 34-39. https://doi.org/10.2337/diacare.23.1.34

V

  1. Valls, C

    1. Total homocysteine in patients with type 1 diabetes.
      C Pavía, I Ferrer, C Valls, R Artuch, C Colomé and M A Vilaseca
      Diabetes Care 2000 Jan; 23 (1): 84-87. https://doi.org/10.2337/diacare.23.1.84

  2. Veglio, M

    1. Effects of exposure at an altitude of 3,000 m on performance of glucose meters.
      O Pecchio, S Maule, M Migliardi, M Trento and M Veglio
      Diabetes Care 2000 Jan; 23 (1): 129-131. https://doi.org/10.2337/diacare.23.1.129a

  3. Verlato, G

    1. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
      M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti and G Verlato
      Diabetes Care 2000 Jan; 23 (1): 45-50. https://doi.org/10.2337/diacare.23.1.45

  4. Vidgen, E

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

  5. Vilaseca, M A

    1. Total homocysteine in patients with type 1 diabetes.
      C Pavía, I Ferrer, C Valls, R Artuch, C Colomé and M A Vilaseca
      Diabetes Care 2000 Jan; 23 (1): 84-87. https://doi.org/10.2337/diacare.23.1.84

  6. Vuksan, V

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

W

  1. Wakasugi, T

    1. Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.
      Y Murase, T Wakasugi, K Yagi and H Mabuchi
      Diabetes Care 2000 Jan; 23 (1): 131-132. https://doi.org/10.2337/diacare.23.1.131

  2. Wei, M

    1. Alcohol intake and incidence of type 2 diabetes in men.
      M Wei, L W Gibbons, T L Mitchell, J B Kampert and S N Blair
      Diabetes Care 2000 Jan; 23 (1): 18-22. https://doi.org/10.2337/diacare.23.1.18

  3. Wolf, A

    1. HbA1c is not recommended as a screening test for diabetes in cystic fibrosis.
      R W Holl, C Buck, C Babka, A Wolf and A Thon
      Diabetes Care 2000 Jan; 23 (1): 126. https://doi.org/10.2337/diacare.23.1.126b

X

  1. Xu, Z

    1. Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: results of a controlled metabolic trial.
      V Vuksan, J L Sievenpiper, R Owen, J A Swilley, P Spadafora, D J Jenkins, E Vidgen, F Brighenti, R G Josse, L A Leiter, Z Xu and R Novokmet
      Diabetes Care 2000 Jan; 23 (1): 9-14. https://doi.org/10.2337/diacare.23.1.9

Y

  1. Yagi, K

    1. Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.
      Y Murase, T Wakasugi, K Yagi and H Mabuchi
      Diabetes Care 2000 Jan; 23 (1): 131-132. https://doi.org/10.2337/diacare.23.1.131

  2. Yu, J G

    1. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
      J P Frias, J G Yu, Y T Kruszynska and J M Olefsky
      Diabetes Care 2000 Jan; 23 (1): 64-69. https://doi.org/10.2337/diacare.23.1.64

Z

  1. Zenere, M B

    1. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
      E Bonora, G Targher, M Alberiche, R C Bonadonna, F Saggiani, M B Zenere, T Monauni and M Muggeo
      Diabetes Care 2000 Jan; 23 (1): 57-63. https://doi.org/10.2337/diacare.23.1.57

  2. Zimmet, P Z

    1. Impaired fasting glucose: how low should it go?
      J E Shaw, P Z Zimmet, A M Hodge, M de Courten, G K Dowse, P Chitson, J Tuomilehto and K G Alberti
      Diabetes Care 2000 Jan; 23 (1): 34-39. https://doi.org/10.2337/diacare.23.1.34

  3. Zoppini, G

    1. Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
      M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti and G Verlato
      Diabetes Care 2000 Jan; 23 (1): 45-50. https://doi.org/10.2337/diacare.23.1.45
Back to top